Literature DB >> 15561011

Risk factors for readmission after neonatal cardiac surgery.

Andrew S Mackie1, Kimberlee Gauvreau, Jane W Newburger, John E Mayer, Lars C Erickson.   

Abstract

BACKGROUND: Repeat hospitalizations place a significant burden on health care resources. Factors predisposing infants to unplanned hospital readmission after congenital heart surgery are unknown.
METHODS: This is a single-center, case-control study. Cases were rehospitalized or died within 30 days of discharge following an arterial switch operation (ASO) or Norwood procedure (NP) between 1992 and 2002. Controls underwent an ASO or NP between 1992 and 2002, and were neither readmitted nor died within 30 days of discharge. Patients and controls were matched by gender, year of birth, and procedure. Potential risk factors examined included indices of medical status at the time of discharge, determinants of access to health care, and provider characteristics.
RESULTS: Forty-eight patients were readmitted; 19 of 498 (3.8%) following an ASO and 29 of 254 (11.4%) after a NP (p < 0.001). Six infants died within 30 days of discharge; 1 after an ASO and 5 after a NP. In multivariate analysis, predictors of readmission or death were: residual hemodynamic problem(s) (odds ratio [OR] 4.10 [1.18, 14.3], p = 0.026); an intensive care unit stay greater than 7 days (OR 5.17 [1.12, 23.9] p = 0.035) (ASO); residual hemodynamic problem(s) (OR 5.84 [1.98, 17.2], p = 0.001); and establishment of full oral intake less than 2 days before discharge (OR 5.83 [1.83, 18.6], p = 0.003) (NP). Combining both groups, living in a low income Zip Code (< 30,000 dollars/annum) was associated with a lower likelihood of readmission (OR 0.25 [0.07, 0.85], p = 0.027).
CONCLUSIONS: Residual hemodynamic problem(s) predispose to hospital readmission after the ASO and NP. Low socioeconomic status may reduce the likelihood of readmission even when problems arise.

Entities:  

Mesh:

Year:  2004        PMID: 15561011     DOI: 10.1016/j.athoracsur.2004.05.047

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Regionalization in neonatal congenital heart surgery: the impact of distance on outcome after discharge.

Authors:  Nelangi M Pinto; Javier Lasa; Troy E Dominguez; Gil Wernovsky; Sarah Tabbutt; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2011-09-29       Impact factor: 1.655

2.  Factors prolonging length of stay in the cardiac intensive care unit following the arterial switch operation.

Authors:  Derek S Wheeler; Catherine L Dent; Peter B Manning; David P Nelson
Journal:  Cardiol Young       Date:  2007-12-20       Impact factor: 1.093

3.  Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: risk factors and their interaction with shunt type.

Authors:  James S Tweddell; Lynn A Sleeper; Richard G Ohye; Ismee A Williams; Lynn Mahony; Christian Pizarro; Victoria L Pemberton; Peter C Frommelt; Scott M Bradley; James F Cnota; Jennifer Hirsch; Paul M Kirshbom; Jennifer S Li; Nancy Pike; Michael Puchalski; Chitra Ravishankar; Jeffrey P Jacobs; Peter C Laussen; Brian W McCrindle
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-15       Impact factor: 5.209

4.  Is race associated with morbidity and mortality after hospital discharge among neonates undergoing heart surgery?

Authors:  Javier J Lasa; Meryl S Cohen; Gil Wernovsky; Nelangi M Pinto
Journal:  Pediatr Cardiol       Date:  2012-08-29       Impact factor: 1.655

5.  Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Luca Vricella; Marshall L Jacobs; Jeffrey P Jacobs; Chirag R Parikh; Sara K Pasquali; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2019-07-16       Impact factor: 4.330

6.  Risk factors for unplanned readmission within 30 days after pediatric neurosurgery: a nationwide analysis of 9799 procedures from the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Brandon A Sherrod; James M Johnston; Brandon G Rocque
Journal:  J Neurosurg Pediatr       Date:  2016-05-17       Impact factor: 2.375

7.  Palivizumab use among children with congenital heart disease in Quebec: Impact of Canadian guidelines on clinical practice.

Authors:  Marc Bellavance; Charles V Rohlicek; Jean-Luc Bigras; Jean-Marc Côté; Marc Paquet; Marc H Lebel; Andrew S Mackie
Journal:  Paediatr Child Health       Date:  2006-01       Impact factor: 2.253

8.  Risk Factors for Interstage Mortality Following the Norwood Procedure: Impact of Sociodemographic Factors.

Authors:  Laura C Taylor; Brendan Burke; Janet E Donohue; Sunkyung Yu; Jennifer C Hirsch-Romano; Richard G Ohye; Caren S Goldberg
Journal:  Pediatr Cardiol       Date:  2015-08-11       Impact factor: 1.655

9.  Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery.

Authors:  Jeremiah R Brown; Meagan E Stabler; Devin M Parker; Luca Vricella; Sara Pasquali; JoAnna K Leyenaar; Andrew R Bohm; Todd MacKenzie; Chirag Parikh; Marshall L Jacobs; Jeffrey P Jacobs; Allen D Everett
Journal:  Cardiol Young       Date:  2019-07-10       Impact factor: 1.093

10.  ST2 Predicts Risk of Unplanned Readmission Within 1 Year After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Marshall L Jacobs; Jeffrey P Jacobs; Luca Vricella; Heather Thiessen-Philbrook; Chirag R Parikh; Cedric Manlhiot; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2020-04-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.